Covid-19 news
Federal Regulators are expected to amend the emergency use authorizations for the Pfizer and Moderna vaccines to allow for a third shot of coronavirus vaccine as soon as Thursday for some immune compromised people, multiple reports said Wednesday.
An official familiar with the plan told New York Times that the third shot covers those with solid organ transplant and others who immune systems are similarly compromised, roughly 10 million Americans. A May study from John Hopkins University School of Medicine found that only 17% of transplant recipients have antibodies after their first dose of the covid-19 vaccine, with an additional 35% responding after two shots.
The reported decision comes as the Delta variant surges throughout the United States. It accounts for about 93% of the nation's cases among all of its iterations.
SEE MORE HERE:
Commentaires